RNA methylation in cardiac hypertrophy and heart failure

Back

ESC Premium Access

RNA methylation in cardiac hypertrophy and heart failure

Session: Heart Failure: new targets for treatment

Topic: Genetics, Epigenetics, ncRNA

Speaker: Mr E. Buchholz (Gottingen, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Eric Buchholz

University Medical Center of Gottingen (UMG), Gottingen (Germany)

0 follower

5 more presentations in this session

Angiotensin II-dependent activation of NADPH oxidase 4 contributes to muscle wasting in mice via downregulation of NF-E2-related factor 2

Speaker: Doctor T. Kadoguchi (Tokyo, JP)

Excessive mitochondrial reactive oxygen species emission from circulating blood cells is associated with severity of heart failure and exercise intolerance

Speaker: Doctor R. Shirakawa (Sapporo, JP)

Positive cardiac inotropy by carvedilol via unique beta-arrestin2-dependent SERCA2a stimulation

Speaker: Associate Professor A. Lymperopoulos (Fort Lauderdale, US)

Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes

Speaker: Mr J. Mustroph (Regensburg, DE)

HECTD3 attenuates cardiac hypertrophy acting as an E3 ligase of SUMO2

Speaker: Doctor A. Rangrez (Kiel, DE)

Access

Abstract

Access the full session

Heart Failure: new targets for treatment

Speakers: Mr E. Buchholz, Doctor T. Kadoguchi, Doctor R. Shirakawa, Associate Professor A. Lymperopoulos, Mr J. Mustroph...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources